Virtual Medicinal Product (VMP) - Taurolidine 2% nebuliser liquid
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Taurolidine 2% nebuliser liquid | Start Date 08-06-2010 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Inhalation
- Form
- Nebuliser liquid
- Ontology Form/Route
- solutionnebuliser.inhalation
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- B05CA05
- BNF Codes
-
- BNF code 05010700
| Code | Start Date | End Date |
|---|---|---|
| 17335611000001108 | 08-06-2010 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Taurolidine | Based on Ingredient Substance | 20 mg | 1 ml |
Name
Taurolidine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMTaurolidine
-
VMP(Current) Taurolidine 2% nebuliser liquid
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |